In 2023, Devagene was founded to open a new chapter of excellence and innovation in nutritional supplements and bioactive formulations. Our beginning was not by chance — it was the result of a strategic alliance of Egyptian investors and experts with deep experience in pediatric medicines, especially the precise formulas trusted and recommended by leading pediatric neurologists.
At Devagene, we combine a deep understanding of children’s neurological needs with high international standards of bioactive manufacturing, delivering solutions that help improve family quality of life and support a brighter future for the next generation.
After years of research, development, and scientific review, Devagene launched its first products in June 2026: Citimoria for cognitive and language support, and Gardoxin for energy, nervous system wellness, and immune resilience.